Cardiology at the Limits
Derek M. Yellon, Lionel H. Opie
Juta and Company Ltd, Jun 4, 2003 - Cardiology - 169 pages
This is the sixth in a series of symposia that test and re-test the limits of our cardiological knowledge. The first symposium in 1997 was dedicated to the initiation of the Chair of Cellular Cardiology, a joint venture between the University of Cape Town and University College London. Subsequent symposia celebrated the ongoing collaboration of the two universities, the two Hatter Institutes, and the Chair of Cellular Cardiology that bridges them.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Dilemmas in research and practice
The Hatter Lecture
New imaging techniques to define the limits
PPARs at the limits of diabetes
a harbinger of heart disease
Passing from the limits of hypertension to heart
what are the limits?
Clinical applications of cardiac memory
abnormalities activation acute apoptosis apoptotic assessment atherosclerotic plaque Badimon JJ Biol calcification calcium score cardiac memory Cardiology cardiomyocytes cardiovascular Circulation clinical Coll Cardiol computed tomography contrast contrast-enhanced coronary angiography coronary artery disease demonstrated detection diabetic heart diabetic nephropathy dobutamine dysfunction EBCT ejection fraction endothelial Engl evaluation fatty acid Figure flow reserve function Fuster gene heart failure human hypertension hypertrophy increased ischemic left ventricular lipid macrophages magnetic resonance imaging metabolic MHC-PPAR mice microalbuminuria mitochondrial myoblast myocardial blood flow myocardial infarction myocardial perfusion myocardial viability myocardium myocytes noninvasive normal oxidation pathways perfusion imaging peroxisomal positron emission tomography potential PPAR PPARa protein recently receptor reduced remodeling revascularization risk factors Schwaiger skeletal muscle skeletal myoblasts smooth muscle cells SPECT stem cells stenosis studies systolic target technique therapy thrombus tion tissue transgenic transplantation treatment trials type 2 diabetes uptake vascular smooth muscle vivo wall